MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jul 23, 2026MOH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
MOH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 23 de Maio de 2011 | 3-for-2 | Para frente |
Sobre Molina Healthcare Inc Common Stock Visão geral da empresa da Wikipedia
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
History
Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.
Leadership
For twenty years, the company was run by Dr. Molina's son, J. Mario Molina, MD, a physician. He was the president and CEO of the company. John Molina, Mario's younger brother, was the CFO of Molina Healthcare. The two took over Molina's operations after their father died in 1996 and continued to expand the company. In May 2017 Dr. J. Mario Molina and John Molina were removed from their positions by the Board of Directors, who cited poor financial performance as the reason for the change in leadership. Though the board also discused their displeasure in the CEO and CFO criticising President Donald Trump.[3][4] In October 2017 the company announced Joseph Zubretsky, the former CFO of Aetna, as Molina Healthcare's president and CEO.
Clinics
The first Molina Medical clinic was opened in Wilmington, California in 1980. The company formerly operated clinics in Washington, New Mexico, Florida and Utah. The clinics were opened to provide health care to low-income families and individuals. In August 2017 Molina Healthcare announced it would close several clinics in Michigan, Florida, New Mexico, Wisconsin, and Utah.
Becoming HMO
Molina Healthcare has focused on government-paid healthcare programs such as SCHIP and Medicaid since it became a health maintenance organization in 1985. From 1985 to 1997, the company was based solely in California.
Expansion of health plans
1997: Molina Healthcare acquires Health Reach Family Health Care and enters the states of Utah and Michigan.
2000: Molina Healthcare enters the state of Washington.
2004: Molina Healthcare enters the state of New Mexico.
2005: Molina Healthcare becomes a health plan in Ohio.
2006: Molina Healthcare enters the state of Texas.
2007: Molina Healthcare enters Missouri.
2008: Molina Healthcare enters Florida.
2010: Molina Healthcare enters Wisconsin.
2012: Molina Healthcare enters Illinois.
2013: Molina Healthcare enters South Carolina by acquiring assets from Community Health Solutions.
2013: Molina Healthcare acquires New Mexico Lovelace Medicaid contract.
2014: Molina Healthcare acquires Florida Medicaid assets from First Coast Advantage.
2015: Molina Healthcare enters Chicago market, acquiring MyCare Chicago's Medicaid assets.
2015: Molina Healthcare enters Puerto Rico.
2015: Molina Healthcare of Washington is the first health care company in the state to cover "Virtual Urgent Care" services.
2015: Molina Healthcare acquires Medicaid assets of Integral Health Plan, Inc. in Florida.
2015: Molina Healthcare acquires Providence Human Services and Community Services from Providence Service Corporation and renames them Pathways.
2015: Molina Healthcare adds online access to behavioral health.
2015: Molina Healthcare acquires HealthPlus MIChild and Medicaid programs of Michigan.
2015: Molina Healthcare acquires assets of Loyola Physician Partners' Medicaid Program of Illinois.
2017: Molina Healthcare exits the individual Marketplace in Utah and Wisconsin.
2018: Molina Healthcare loses Medicaid contract with the state of New Mexico.
2018: Molina Healthcare sells Pathways to Altar Capital
2019: Molina Healthcare loses Medicaid contract with the state of Texas.
2020: Molina Healthcare acquires Passport Health Plan in Kentucky.
2021: Molina Healthcare acquires Magellan Complete Care line of business from Magellan Health, Inc. With this acquisition, Molina enters Arizona, Massachusetts, and Virginia.
2021: Molina Healthcare acquires Affinity Health Plan in New York.
2021: Molina Healthcare acquires Cigna's Medicaid contracts in Texas.
2023: Molina Healthcare enters Iowa.
2023: Molina Healthcare loses Medicad contract with the state of Indiana.
2024: Molina Healthcare loses Medicaid contracts with the states of Virginia and Florida.
Going public
Molina Healthcare filed with the Securities and Exchange Commission for an initial stock offering in December 2002 and went public in July 2003 with a stock offering of $102 million. The shares were priced at $17.50, and Molina raised approximately $124 million in the initial public offering. In its stock market debut, Molina sold 6.6 million shares at $20.30, making the company the third-best first day gainer of 2003. Molina Healthcare was the first company from Inc. Magazine's "Inner City 100" list to go public.
Entering the Medicare market
Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.
Entering MMIS market
Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.
Entering health insurance marketplace
In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.
Dual eligible demonstration projects
Molina was selected to participate in dual eligible demonstration projects in California, Ohio, Illinois, Michigan, South Carolina and Texas to serve patients who are eligible for both Medicare and Medicaid.
Criticism and controversies
A 2023 report investigating "High Rates of Prior
Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.
Philanthropy
In May 2022, MolinaCares presented a $100,000 grant to support Compass Health's Broadway Campus Redevelopment Project. The grant will aid funding of construction of a 72,000 square-foot, state-of-the-art facility that will expand community-based behavioural health care services and its workforce in northwest Washington.
In August 2026, MolinaCares awarded a grant of $150,000 to literacy non-profit Indy Reads, to launch a new program in health literacy, in partnership with Molina Healthcare.
Awards and recognition
Molina Healthcare was awarded the 2011 Alfred P. Sloan Award for Business Excellence in Workplace Flexibility. The award ranked Molina Healthcare in the top 20 percent of employers nationally in terms of its programs, policies and culture for creating an effective and flexible workplace. In 2006, Molina Healthcare was named among the 100 best corporate citizens by Business Ethics magazine. In 2005, Time magazine recognized Dr. J. Mario Molina, then CEO of Molina Healthcare, as one of the 25 most influential Hispanics in America.
The company ranked 155th on the 2021 Fortune 500 list of the largest United States corporations by revenue. The company ranked 126th on the 2023 Fortune 500 list of the largest United States corporations by revenue.
Other awards and recognition
2014: Milwaukee Journal Sentinel Recognizes Molina Healthcare of Wisconsin with a Top Workplace Award 2014
2014: Molina Healthcare of New Mexico voted Best Places to Work by Albuquerque Business First
2014: Molina Healthcare was one of 26 companies to participate in President Obama's SupplierPay 2014
2015: Molina Healthcare voted Top Ten Least Stressful Companies to Work for In America 2015
2015: Molina Healthcare ranked 301 in top Fortune 500 2015
2016: Molina Healthcare ranked 201 in top Fortune 500 2016
2017: Molina Healthcare ranked 156 in Fortune 500 2017
2023: Molina Healthcare of Kentucky awarded One of Kentucky's Best Places to Work
2023: Molina Healthcare recognized as one of America's Best-in-State Employers by Forbes
2023: Molina Healthcare recognized as one of Time's World's Best Companies of 2023
2023: Molina Healthcare recognized as one of Newsweek's Greatest Workplaces for Parents and Families 2023
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | MOH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.0média 5A ≈21.1 | ≈21.1 | 36.3 | Sobreavaliado | |
| P/S (TTM) | 0.2média 5A ≈0.5 | ≈0.5 | 0.7 | Subvalorizado | |
| P/B (MRQ) | 2.4média 5A ≈4.3 | ≈4.3 | 3.9 | Subvalorizado | |
| EV / EBITDA (TTM) | 12.7média 5A ≈7.0 | ≈7.0 | 16.1 | Subvalorizado | |
| Preço / FCF (TTM) | 36.4média 5A ≈14.4 | ≈14.4 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 27.0média 5A ≈11.5 | ≈11.5 | · | · | |
| EV / Receita (TTM) | 0.1média 5A ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 17.4média 5A ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (Preço / Valor Patrimonial Tangível) | 5.3média 5A ≈7.7 | ≈7.7 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | MOH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 0.46%média 5A ≈3.6% | ≈3.6% | 3.5% | Fraco | |
| Margem EBITDA (TTM) | 0.83%média 5A ≈4.1% | ≈4.1% | 3.7% | Fraco | |
| Margem de Impostos Pré-Tributação (TTM) | -0.01%média 5A ≈3.2% | ≈3.2% | 2.8% | Fraco | |
| Margem de Lucro Líquido (TTM) | -0.02%média 5A ≈2.4% | ≈2.4% | 2.9% | Fraco | |
| ROA (TTM) | -0.04%média 5A ≈6.3% | ≈6.3% | 3.0% | Em linha | |
| ROE (TTM) | -0.16%média 5A ≈23.1% | ≈23.1% | 10.1% | Em linha | |
| ROIC | 8.0%média 5A ≈15.3% | ≈15.3% | 8.0% | Em linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | MOH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 0.9média 5A ≈0.7 | ≈0.7 | 0.7 | Dívida alta | |
| Índice de liquidez corrente (MRQ) | 1.7média 5A ≈1.5 | ≈1.5 | 1.7 | Em linha | |
| Índice de Liquidez Seca (MRQ) | 1.6média 5A ≈1.5 | ≈1.5 | 1.3 | Liquidez forte | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 0.9média 5A ≈0.7 | ≈0.7 | 0.7 | Dívida alta |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | MOH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 11.8%média 5A ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 12.4%média 5A ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 18.5% | · | · | · | |
| EPS YoY | -56.3%média 5A ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -60.0%média 5A ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | -13.0%média 5A ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | -15.8%média 5A ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -6.9% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | MOH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 2.9média 5A ≈2.6 | ≈2.6 | 2.4 | Primeira linha | |
| Receivables Turnover (Giro de Contas a Receber) | 13.3média 5A ≈13.5 | ≈13.5 | 16.3 | Abaixo da média | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$2.4M | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 21, 2026 | $1.51 | $1.40 | 7.5% |
| 31 de Março de 2026 | $2.35 | $1.94 | 21.0% | |
| 31 de Dezembro de 2025 | $-2.75 | $0.34 | -916.0% | |
| 30 de Setembro de 2025 | $1.84 | $3.94 | -53.3% | |
| 30 de Junho de 2025 | $5.48 | $5.85 | -6.3% | |
| 31 de Março de 2025 | $6.08 | $6.02 | 1.1% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| Margem Operacional % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| Lucro líquido | $472M | $1.18B | $1.09B | $792M | $659M |
| EPS Diluído | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| Índice de liquidez corrente | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| Índice de Liquidez Seca | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-636M | $544M | $1.58B | $682M | $2.04B |
Investidores institucionais (13F) 673 declarantes · $13.8B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 159 (+18 vs trimestre anterior) | 68 (-75 vs trimestre anterior) | 219 (+23 vs trimestre anterior) | 181 (+8 vs trimestre anterior) | +1.1M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $1.503.052.088 | 6.572.156 | 10,91% | Ações |
| VANGUARD GROUP INC | $1.055.736.837 | 6.083.536 | 7,66% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $806.903.452 | 3.560.601 | 5,86% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638.128.574 | 2.790.243 | 4,63% | Ações |
| Capital World Investors | $586.138.203 | 2.562.913 | 4,26% | Ações |
| Lingotto Investment Management LLP | $574.377.763 | 2.511.490 | 4,17% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $538.648.191 | 2.355.261 | 3,91% | Ações |
| FMR LLC | $427.964.063 | 1.871.290 | 3,11% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $427.014.918 | 1.867.140 | 3,10% | Ações |
| STATE STREET CORP | $401.475.303 | 1.755.467 | 2,91% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $318.659.985 | 1.393.338 | 2,31% | Ações |
| GOLDMAN SACHS GROUP INC | $298.810.862 | 1.306.563 | 2,17% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $289.810.242 | 1.267.207 | 2,10% | Ações |
| TWO SIGMA INVESTMENTS, LP | $289.611.501 | 1.266.338 | 2,10% | Ações |
| Capital Research Global Investors | $249.797.804 | 1.092.251 | 1,81% | Ações |
| MORGAN STANLEY | $230.316.927 | 1.007.068 | 1,67% | Ações |
| HARRIS ASSOCIATES L P | $218.980.250 | 957.500 | 1,59% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $204.005.369 | 891.772 | 1,48% | Ações |
| 8 KNOTS MANAGEMENT, LLC | $198.942.438 | 1.146.378 | 1,44% | Ações |
| MANNING & NAPIER ADVISORS LLC | $152.338.582 | 663.669 | 1,11% | Ações |
| UBS Group AG | $142.749.967 | 624.180 | 1,04% | Ações |
| Long Focus Capital Management, LLC | $139.507.000 | 610.000 | 1,01% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131.512.792 | 575.045 | 0,95% | Ações |
| TWO SIGMA ADVISERS, LP | $116.582.437 | 671.790 | 0,85% | Ações |
| Invesco Ltd. | $116.332.600 | 508.669 | 0,84% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115.548.617 | 505.241 | 0,84% | Ações |
| NORTHERN TRUST CORP | $88.292.838 | 386.064 | 0,64% | Ações |
| NORGES BANK | $87.054.426 | 380.649 | 0,63% | Ações |
| Bank of New York Mellon Corp | $86.138.019 | 376.642 | 0,63% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82.789.400 | 362.000 | 0,60% | Opção de venda |
| BNP PARIBAS FINANCIAL MARKETS | $82.559.556 | 360.995 | 0,60% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $75.497.758 | 330.117 | 0,55% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $72.051.935 | 315.050 | 0,52% | Ações |
| BANK OF AMERICA CORP /DE/ | $71.479.956 | 312.549 | 0,52% | Ações |
| Amundi | $59.944.786 | 262.111 | 0,44% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $57.795.692 | 252.714 | 0,42% | Ações |
| Maple Rock Capital Partners Inc. | $55.642.710 | 243.300 | 0,40% | Ações |
| Russell Investments Group, Ltd. | $53.133.740 | 232.165 | 0,39% | Ações |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52.660.005 | 230.258 | 0,38% | Ações |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51.238.863 | 224.044 | 0,37% | Ações |
| D. E. Shaw & Co., Inc. | $47.575.775 | 208.027 | 0,35% | Ações |
| CITIGROUP INC | $47.390.070 | 207.215 | 0,34% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46.357.490 | 202.700 | 0,34% | Opção de compra |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45.740.000 | 200.000 | 0,33% | Ações |
| DEUTSCHE BANK AG\ | $45.272.766 | 197.957 | 0,33% | Ações |
| INVESTMENT HOUSE LLC | $44.310.854 | 193.751 | 0,32% | Ações |
| JANE STREET GROUP, LLC | $43.224.300 | 189.000 | 0,31% | Opção de venda |
| Fiera Capital Corp | $43.130.075 | 188.588 | 0,31% | Ações |
| Summit Street Capital Management, LLC | $41.630.489 | 182.031 | 0,30% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41.211.511 | 180.199 | 0,30% | Ações |
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 declarações | 23 de Janeiro de 2018 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 62 insiders · 25 diretores · 19 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 22 de Agosto de 2007 S | 5.734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 1 de Julho de 2005 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 1 de Março de 2026 A | 83.251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 6 de Junho de 2018 D | 48.390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 30 de Junho de 2026 A | 90.178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 2 de Fevereiro de 2018 D | 28.730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 1 de Julho de 2026 F | 21.636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 30 de Junho de 2026 A | 67.313 | 0 | 1 | $-3.314.983 |
| Marc Russo | EVP, Health Plans | 7 de Agosto de 2023 S | 37.093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 1 de Março de 2020 F | 8.846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 1 de Março de 2018 F | 25.084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 30 de Junho de 2017 A | 29.441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 16 de Agosto de 2010 S | 16.782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 1 de Julho de 2010 F | 51.006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 5 de Dezembro de 2008 J | 50.000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 7 de Agosto de 2008 F | 16.199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 30 de Junho de 2008 A | 15.304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 29 de Junho de 2007 A | 7.822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 1 de Março de 2007 A | 5.150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 1 de Março de 2007 A | 8.500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 1 de Março de 2007 A | 8.713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 28 de Fevereiro de 2007 S | 4.774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 16 de Fevereiro de 2007 F | 5.000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 30 de Dezembro de 2005 J | 12.564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 16 de Agosto de 2004 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | Conselheiro | 1 de Outubro de 2026 A | 4.688 | 0 | 0 | $0 |
| Richard M Schapiro | Conselheiro | 1 de Outubro de 2026 A | 12.615 | 0 | 1 | $-51.058 |
| Richard C Zoretic | Conselheiro | 1 de Outubro de 2026 A | 9.693 | 1 | 0 | $100.128 |
| Leo P Grohowski | Conselheiro | 1 de Outubro de 2026 A | 1.846 | 0 | 0 | $0 |
| Francis S Soistman JR | Conselheiro | 1 de Outubro de 2026 A | 1.211 | 0 | 0 | $0 |
| Dale B Wolf | Conselheiro | 1 de Outubro de 2026 A | 15.937 | 0 | 0 | $0 |
| Steven J Orlando | Conselheiro | 1 de Outubro de 2026 A | 18.271 | 0 | 0 | $0 |
| Ronna Romney | Conselheiro | 1 de Outubro de 2026 A | 18.173 | 0 | 1 | $-74.342 |
| Barbara L Brasier | Conselheiro | 1 de Outubro de 2026 A | 6.122 | 0 | 0 | $0 |
| Daniel Cooperman | Conselheiro | 1 de Abril de 2025 A | 6.383 | 0 | 0 | $0 |
| Garrey Carruthers | Conselheiro | 1 de Abril de 2021 A | 5.265 | 0 | 0 | $0 |
| Charles Z Fedak | Conselheiro | 1 de Abril de 2019 A | 19.092 | 0 | 0 | $0 |
| John C Molina | Conselheiro | 20 de Fevereiro de 2018 S | 372.930 | 0 | 0 | $0 |
| Frank E Murray MD | Conselheiro | 1 de Outubro de 2017 A | 16.811 | 0 | 0 | $0 |
| Steven James | Conselheiro | 1 de Abril de 2016 A | 15.024 | 0 | 0 | $0 |
| John P Szabo JR | Conselheiro | 1 de Abril de 2015 A | 17.097 | 0 | 0 | $0 |
| Sally K Richardson | Conselheiro | 3 de Maio de 2012 A | 47.537 | 0 | 0 | $0 |
| Wayne B Lowell | Conselheiro | 10 de Maio de 2007 A | 10.011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | Conselheiro | 10 de Fevereiro de 2004 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | Detentor de 10% | 14 de Dezembro de 2009 J | 2.137.134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | Detentor de 10% | 22 de Junho de 2006 S | 2.926.907 | 0 | 0 | $0 |
| Maurice Hebert | · | 14 de Maio de 2026 S | 12.815 | 0 | 1 | $-114.930 |
| Joseph M Zubretsky | · | 1 de Março de 2026 A | 99.015 | 0 | 0 | $0 |
| Thomas L Tran | · | 24 de Maio de 2021 F | 29.775 | 0 | 0 | $0 |
| Norman Nichols | · | 8 de Agosto de 2018 S | 47.415 | 0 | 0 | $0 |
| Harold Gooch | · | 30 de Junho de 2018 A | 7.063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 11 de Dezembro de 2017 S | 61.125 | 0 | 0 | $0 |
| James W Howatt | · | 19 de Março de 2010 S | 34.081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 5 de Novembro de 2009 G | 1.200 | 0 | 0 | $0 |
| Josephine M Molina | · | 6 de Agosto de 2008 J | 345.701 | 0 | 0 | $0 |
| Janet M Watt | · | 6 de Agosto de 2008 J | 284.641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 6 de Agosto de 2008 J | 345.701 | 0 | 0 | $0 |
| Zarina Sparling | · | 21 de Fevereiro de 2008 M | 9.380 | 0 | 0 | $0 |
| Mary R Molina | · | 27 de Setembro de 2006 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 11 de Maio de 2006 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 30 de Junho de 2005 J | 1.908 | 0 | 0 | $0 |
| David W Erickson | · | 2 de Dezembro de 2004 M | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 74 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4,23% | 18.894 NS | 31 de Julho de 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 1,71% | 120.017 SH | 2 de Outubro de 2026 | Diário |
| RFV · Invesco Exchange-Traded Fund Trust | 1,66% | 29.907 SH | 2 de Outubro de 2026 | Diário |
| IHF · iShares Trust | 1,53% | 100.080 SH | 11 de Setembro de 2026 | Diário |
| VIOV · VANGUARD ADMIRAL FUNDS | 1,28% | 110.553 SH | 19 de Agosto de 2026 | Diário |
| PIZ · Invesco Exchange-Traded Fund Trust … | 1,17% | 105.488 SH | 2 de Outubro de 2026 | Diário |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 5.983.000 | 2 de Outubro de 2026 | Diário |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,64% | 182.154 SH | 19 de Agosto de 2026 | Diário |
| FFLV · FIDELITY COVINGTON TRUST | 0,41% | 343 NS | 31 de Julho de 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,40% | 6.790 NS | 31 de Julho de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,31% | 7.103 SH | 2 de Outubro de 2026 | Diário |
| DFAT · Dimensional ETF Trust | 0,27% | 198.247 NS | 31 de Julho de 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,26% | 8.610 NS | 31 de Julho de 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,25% | 758.589 SH | 19 de Agosto de 2026 | Diário |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 22.626 NS | 31 de Julho de 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,22% | 765 NS | 31 de Julho de 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,20% | 3.918 NS | 31 de Julho de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 156.577 SH | 19 de Agosto de 2026 | Diário |
| ESML · iShares Trust | 0,17% | 23.899 SH | 11 de Setembro de 2026 | Diário |
| IYH · iShares Trust | 0,17% | 30.059 SH | 11 de Setembro de 2026 | Diário |
| DFSV · Dimensional ETF Trust | 0,16% | 67.624 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,16% | 7.446 SH | 11 de Setembro de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,15% | 24.870 NS | 31 de Julho de 2026 | N-PORT |
| SMMD · iShares Trust | 0,14% | 27.458 SH | 11 de Setembro de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1.195.007 SH | 19 de Agosto de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,13% | 597.850 SH | 19 de Agosto de 2026 | Diário |
| IWS · iShares Trust | 0,10% | 77.233 SH | 11 de Setembro de 2026 | Diário |
| WSML · iShares Trust | 0,10% | 3.305 SH | 11 de Setembro de 2026 | Diário |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,09% | 4.929 SH | 2 de Outubro de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,09% | 68.863 NS | 31 de Julho de 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3.775 SH | 2 de Outubro de 2026 | Diário |
| IWR · iShares Trust | 0,08% | 210.604 SH | 11 de Setembro de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 35.013 SH | 2 de Outubro de 2026 | Diário |
| EMGF · iShares, Inc. | 0,06% | 15.805 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,05% | 1.409 NS | 31 de Julho de 2026 | N-PORT |
| EMXC · iShares, Inc. | 0,05% | 162.911 SH | 11 de Setembro de 2026 | Diário |
| DFSU · Dimensional ETF Trust | 0,04% | 5.157 NS | 31 de Julho de 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,03% | 305 NS | 31 de Julho de 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 45.470 SH | 11 de Setembro de 2026 | Diário |
| IEMG · iShares, Inc. | 0,03% | 689.771 SH | 11 de Setembro de 2026 | Diário |
| EEM · iShares, Inc. | 0,03% | 131.827 SH | 11 de Setembro de 2026 | Diário |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 31.058 SH | 19 de Agosto de 2026 | Diário |
| IWD · iShares Trust | 0,03% | 114.206 SH | 11 de Setembro de 2026 | Diário |
| DFUV · Dimensional ETF Trust | 0,03% | 20.443 NS | 31 de Julho de 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,03% | 52.472 SH | 11 de Setembro de 2026 | Diário |
| TILT · FlexShares Trust | 0,02% | 2.686 NS | 31 de Julho de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1.655.258 SH | 19 de Agosto de 2026 | Diário |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 868.836 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8.548 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 4.354 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,02% | 11.634 SH | 19 de Agosto de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,02% | 45.023 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 2.946 NS | 31 de Julho de 2026 | N-PORT |
| IXUS · iShares Trust | 0,02% | 126.782 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,01% | 14.718 SH | 11 de Setembro de 2026 | Diário |
| IWB · iShares Trust | 0,01% | 35.396 SH | 11 de Setembro de 2026 | Diário |
| IYY · iShares Trust | 0,01% | 2.168 SH | 11 de Setembro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,01% | 15.184 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 67.059 SH | 11 de Setembro de 2026 | Diário |
| DFAU · Dimensional ETF Trust | 0,01% | 8.285 NS | 31 de Julho de 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,01% | 531.000 SH | 11 de Setembro de 2026 | Diário |
| VOXP · Advisors Series Trust | 0,01% | 3 NS | 31 de Julho de 2026 | N-PORT |
| ACWX · iShares Trust | 0,01% | 16.724 SH | 11 de Setembro de 2026 | Diário |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 910.737 SH | 19 de Agosto de 2026 | Diário |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 145.760 SH | 19 de Agosto de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89.282 SH | 19 de Agosto de 2026 | Diário |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,01% | 68.906 SH | 19 de Agosto de 2026 | Diário |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.303 SH | 2 de Outubro de 2026 | Diário |
| ACWI · iShares Trust | 0,00% | 8.307 SH | 11 de Setembro de 2026 | Diário |
| IJH · iShares Trust | · | 1.828.162 SH | 11 de Setembro de 2026 | Diário |
| IJJ · iShares Trust | · | 265.658 SH | 21 de Agosto de 2026 | Diário |
| ISCB · iShares Trust | · | 2.352 SH | 11 de Setembro de 2026 | Diário |
| ISCV · iShares Trust | · | 6.481 SH | 11 de Setembro de 2026 | Diário |
| SMMV · iShares Trust | · | 4.872 SH | 1 de Setembro de 2026 | Diário |
MOH Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
17 analistas · 2026-09-30Alvo médio $209.12 +10,3%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.